A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4045 (2006.01) A61K 31/165 (2006.01) A61K 31/27 (2006.01) A61K 31/4035 (2006.01) A61K 31/4439 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61P 1/04 (2006.01) A61P 13/00 (2006.01)
Patent
CA 2614698
The invention relates to the use of a compound acting as mGluR5 antagonist in the treatment, preventions and/or delay of progression of disorders of the gastro-intestinal tract, disorders of the urinary tract and/or post-operative disorders and to the treatment, prevention and/or delay of progression of pain associated with these indications.
La présente invention concerne l'emploi d'un composé agissant en tant qu'antagoniste de mGluR5 dans le traitement, la prévention et/ou le retard de la progression de troubles du tractus gastro-intestinal, de troubles de l'appareil urinaire et/ou de troubles postopératoires. La présente invention concerne également le traitement, la prévention et/ou le retard de la progression des douleurs associées à ces pathologies.
Gasparini Fabrizio
Pfannkuche Hans-Juergen
Rouzade-Dominguez Marie-Laure
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of mglur5 (esp. afq056) in gi (esp. gerd) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of mglur5 (esp. afq056) in gi (esp. gerd), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mglur5 (esp. afq056) in gi (esp. gerd) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1467334